Eli Lilly shares suffered a sharp decline on January 15, falling by as much as 4.87% despite overall U.S. markets advancing during the session.
- The stock traded near $1021.02, marking a four-week low, the lowest price recorded since December 2025.
- This steep intraday selling contrasts with the stock's strong long-term performance, having risen 43.73% over the last 12 months.